Imaging of native high-density lipoprotein in human coronary plaques by color fluorescent angioscopy

Circulation Journal

Volumn 78, Issue 7, 2014, Pages 1667-1675

  Uchida, Yasuto ^a   Hiruta, Nobuyuki ^b   Yamanoi, Daisuke ^c   Shimoyama, Ei ^c   Maezawa, Yuko ^d   Uchida, Yasumi ^c  

^a Tsukuba Memorial Hospital   (Japan)

^b TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^c Department of Internal Medicine Chiba Kensei Hospital ^*  (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

Color fluorescent angioscopy; Color fluorescent microscopy; Fast green dye; High density lipoprotein; Human coronary plaques

Indexed keywords

BIOLOGICAL MARKER; FLUORESCENT DYE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; METHYLENE BLUE;

ADULT; ANGIOSCOPY; ARTERY WALL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; COLOR; COLOR FLUORESCENT ANGIOSCOPY; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; HUMAN; HUMAN TISSUE; IMAGING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIPID STORAGE; MALE; PROTEIN LOCALIZATION;

EID: 84903212915     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1585     Document Type: Article

References (30)

1. Assmann G, Schalte H, von Eckerdstein A, Huang Y. High-density lipoprotein cholesterol as a predictors of coronary heart disease risk: The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996; 124 (Suppl): S11-S20.
2. The BIP Study Group. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. Circulation 2000; 102: 21-27.
3. Toth PP, Davidson MH. High-density lipoproteins: Marker of cardiovascular risk and therapeutic target. J Clin Lipidol 2010; 4: 359-364.
4. Cho KH. Biomedical implications of high-density lipoprotein: Its composition, structure, functions, and clinical applications. BMB Rep 2009; 42: 393-400.
5. Peng ZY, Zhao SP, He BM, Peng DQ, Hu M. Protective effect of HDL on endothelial NO production: The role of DDAH/ADMA pathway. Mol Cell Biochem 2011; 351: 243-249.
6. Negi S, Ballantyne CM. Insights from recent meta-analysis: Role of high-density lipoprotein cholesterol in reducing cardiovascular events and rates of atherosclerotic disease progression. J Clin Lipidol 2010; 4: 365-370.
7. Tardif JC. Emerging high-density lipoprotein infusion therapies: Fulfilling the promise of epidemiology? J Clin Lipidol 2010; 4: 399-404.
8. Brewer HB Jr. Clinical review: The evolving role of HDL in the treatment of high-risk patients with cardiovascular disease. J Clin Endocrinol Metab 2011; 96: 1246-1257.
9. Sriram R, Lagerstedt JO, Petriova J, Samardzic H, Kreutzer U, Xie H, et al. Imaging apolipoprotein A1 in vivo. NMR Biomed 2011; 24: 916-924.
10. Heeren J, Bruns O. Nanocrystals: A new tool to study lipoprotein metabolism and atherosclerosis. Curr Pharm Biotechnol 2012; 13: 365-367.
11. Uchida Y, Uchida H, Kawai S, Kanamaru R, Sugiyama Y, Tomaru T, et al. Detection of vulnerable coronary plaques by color fluorescent angioscopy. JACC Cardiovasc Imaging 2010; 3: 398-408.
12. Uchida Y, Uchida Y, Kawai S, Kanamaru R, Kameda N. Imaging of lysophophatidylcholine in human coronary plaques by color fluorescent angioscopy. Int Heart J 2010; 51: 129-133.
13. Uchida Y, Uchida Y, Maezawa Y, Hiruta N, Shimoyama E. Molecular imaging of low-density lipoprotein in human coronary plaques by color fluorescent angioscopy and microscopy. PLoS One 2012; 7: 1-9.
14. Shaik NA, Shaik JP, Ali S, Rao DK. Increased frequency of micronuclei in diabetes mellitus patients using pioglitazone and glimepiride in combination. Food Chem Toxicol 2010; 48: 3432-3435.
15. Rodorigues EB, Penha FM, de Paula Fiod Costa E, Maia M, Moraes M Jr, Meyer CH, et al. Ability of new vital dyes to stain intraocular membranes and tissues in ocular surgery. Am J Ophthalmol 2010; 149: 265-277.
16. Wang F, Ying Z, Duan X, Tan H, Yang B, Guo L, et al. Histomorphometric analysis of adult articular calcified cartilage. J Struct Biol 2009; 168: 359-365.
17. Uchida Y. Clinical classification of coronary plaques. In: Uchida Y, editor. Coronary angioscopy. Armonk, NY: Futura Publishing, 2001; 71-81.
18. Yamada N. Molecular biology of atherosclerosis. Nihon Rinsyo 2002; 60(Suppl 10): 87-94.
19. Uchida Y. Angioscopy systems and their manipulation. In: Uchida Y, editor. Coronary angioscopy. Armonk, NY: Futura Publishing, 2001; 11-28.
20. Uchida Y, Uchida Y, Hiruta N. Histological characteristics of glistening yellow coronary plaques seen on angioscopy. Circ J 2011; 75: 1913-1919.
21. Perek B, Malinska A, Misterski M, Ostalska-Nowicka D, Zabel M, Perek A, et al. Preexisting high expression of matrix metalloproteinase-2 in tunica media of saphenous vein conduits is associated with unfavorable long-term outcomes after coronary artery bypass grafting. Biomed Res Int 2013; 2013: 730721.
22. Onishi I. Immunohistochemistry. In: Onishi I, Kajihara H, Kamiyama R, editors. Pathological examinations. Tokyo, Japan: Bunkodo, 2002; 82-96.
23. Matsuura E, Hughes GR, Khamashta MA. Oxidation of LDL and its clinical implication. Autoimmun Rev 2008; 7: 558-566.
24. Aiyar N, Disa J, Ao Z, Ju H, Nerurkar S, Willette RN, et al. Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells. Mol Cell Biochem 2007; 295: 113-120.
25. Uchida Y, Fujimori Y, Osawa H, Kanai M, Sakurai T, Terasawa K, et al. Angioscopic evaluation of stabilizing effects of bezafibrate on coronary plaque in patients with coronary artery disease. Diagn Ther Endosc 2000; 7: 21-28.
26. Lee M, Jang Y, Kim K, Cho H, See SH. Relationship between HDL3 subclasses and waist circumferences on the prevalence of metabolic syndrome: KMSPI Seoul Study. Atherosclerosis 2010; 213: 288-293.
27. Ozaki Y, Tanaka A, Komukai K, Ishibashi K, Tanimoto T, Kitabata H, et al. High-density lipoprotein cholesterol level is associated with fibrous cap thickness in acute coronary syndrome. Circ J 2013; 77: 2982-2989.
28. Miyauchi K, Daida H, Morimoto T, Hiro T, Kimura T, Nakagawa Y, et al; JAPAN-ACS Investigators. Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy: The extended JAPAN-ACS study. Circ J 2012; 76: 825-832.
29. Uchida Y, Maezawa Y. Molecular imaging of atherosclerotic coronary plaques by color fluorescent angioscopy. In: Schaller B, editor. Molecular imaging. Rijeka: InTec, 2012; 247-268.
30. Uchida Y, Uchida Y, Sugiyama Y, Kanai M, Sakurai T, Shirai S. Two-dimensional visualization of cholesterol and cholesteryl esters within human coronary plaques by near-infrared fluorescence angioscopy. Clin Cardiol 2010; 33: 775-782.